Screening of surface markers on rat intestinal mucosa microfold cells by using laser capture microdissection combined with protein chip technology

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 4, 2014, Pages 932-939

  Zhao, Junyong ^a   Li, Xiaoyu ^a   Luo, Qifeng ^a   Xu, Lei ^a   Chen, Lei ^a   Chai, Li ^a   Huang, Yixiang ^a   Fang, Lin ^a  

^a TONGJI UNIVERSITY   (China)

Author keywords

Laser capture microdissection (LCM); M cells; Marker; Protein chip; Proteomics

Indexed keywords

CELL SURFACE MARKER; CILIARY NEUROTROPHIC FACTOR; CXCL9 CHEMOKINE; INTERLEUKIN 1ALPHA; LIX PROTEIN; PROTEIN; ULEX EUROPAEUS AGGLUTININ; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIGEN ANTIBODY REACTION; ARTICLE; CONTROLLED STUDY; ELECTROSPRAY MASS SPECTROMETRY; FEMALE; FLUORESCENCE MICROSCOPY; IMMUNE RESPONSE; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; IMMUNOLOGICAL TOLERANCE; INTESTINE EPITHELIUM CELL; LASER CAPTURE MICRODISSECTION; LIQUID CHROMATOGRAPHY; MALE; MICROFOLD CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEIN MICROARRAY; RAT;

EID: 84900438113     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Schulz O, Pabst O. Antigen sampling in the small intestine. Trends Immunol 2013; 4: 155-161.
2. Kuolee R, Chen W. M cell-targeted delivery of vaccines and therapeutics. Expert Opin Drug Deliv 2008; 6: 693-702.
3. Azizi A, Kumar A, Diaz-Mitoma F, Mestecky J. Enhancing oral vaccine potency by targeting intestinal M cells. PLoS Pathog 2010; 11: e1001147.
4. Miller H, Zhang J, KuoLee R, Patel GB, Chen W. Intestinal M cells: The fallible sentinels? World J Gastroenterol 2007; 10: 1477-1486.
5. Chou MY, Hartvigsen K, Hansen LF, Fogelstrand L, Shaw PX, Boullier A, Binder CJ, Witztum JL. Oxidation-specific epitopes are important targets of innate immunity. J Intern Med 2008; 5: 479-488.
6. Fujkuyama Y, Tokuhara D, Kataoka K, Gilbert RS, McGhee JR, Yuki Y, Kiyono H, Fujihashi K. Novel vaccine development strategies for inducing mucosal immunity. Expert Rev Vaccines 2012; 3: 367-379.
7. Malik B, Goyal AK, Markandeywar TS, Rath G, Zakir F, Vyas SP. Microfold-cell targeted surface engineered polymeric nanoparticles for oral immunization. J Drug Target 2012; 1: 76-84.
8. Kim SH, Jung DI, Yang IY, Kim J, Lee KY, Nochi T, Kiyono H, Jang YS. M cells expressing the complement C5a receptor are efficient targets for mucosal vaccine delivery. Eur J Immunol 2011; 11: 3219-3229.
9. Fievez V, Plapied L, Plaideau C, Legendre D, des Rieux A, Pourcelle V, Freichels H, Jerome C, Marchand J, Preat V, Schneider YJ. In vitro identification of targeting ligands of human M cells by phage display. Int J Pharm 2010; 1-2: 35-42.
10. Li HF, Zou J, Bai RY, Xing YM, Nie JM, Diao Y. M cell in vitro model and its application in oral delivery of macromolecular drugs. Yao Xue Xue Bao 2011; 12: 1429-1435.
11. Tonry JH, Popov SG, Narayanan A, Kashanchi F, Hakami RM, Carpenter C, Bailey C, Chung MC. In vivo murine and in vitro M-like cell mod-els of gastrointestinal anthrax. Microbes Infect 2013; 1: 37-44.
12. Jourdain S, Bulman A, Dalmasso E. The Lucid Proteomics System for top-down biomarker research. Arch Physiol Biochem 2010; 116: 158-162.
13. Hartmann M, Roeraade J, Stoll D, Templin MF, Joos TO. Protein microarrays for diagnostic assays. Anal Bioanal Chem 2009; 5: 1407-1416.
14. von Eggeling F, Davies H, Lomas L, Fiedler W, Junker K, Claussen U, Ernst G. Tissue-specific microdissection coupled with Protein Chip array technologies: applications in cancer research. Biotechniques 2000; 5: 1066-1070.
15. Verbeke H, Geboes K, Van Damme J, Struyf S. The role of CXC chemokines in the transition of chronic inflammation to esophageal and gastric cancer. Biochim Biophys Acta 2012; 1: 117-129.
16. Singh UP, Venkataraman C, Singh R, Lillard JW Jr. CXCR3 axis: role in inflammatory bowel disease and its therapeutic implication. Endocr Metab Immune Disord Drug Targets 2007; 2: 111-123.
17. Petrasek J, Bala S, Csak T, Lippai D, Kodys K, Menashy V, Barrieau M, Min SY, Kurt-Jones EA, Szabo G. IL-1 receptor antagonist ameliorates inflammasome-dependent alcoholic steatohepatitis in mice. J Clin Invest 2012; 10: 3476-3489.